XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Total
Beginning balance at Dec. 31, 2023 $ 22 $ 1,658,339 $ (929,472) $ (2,119) $ 6,877 $ 733,647
Beginning balance (in shares) at Dec. 31, 2023 223,026,966          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   231       231
Issuance of common stock (in shares) 236,089          
Shares withheld related to net share settlement   (304)       (304)
Stock-based compensation   2,629       2,629
Stock-based sales incentive charges   12,897       12,897
Net loss     (18,443)   (173) (18,616)
Other comprehensive income (loss)       (875) 0 (875)
Ending balance at Mar. 31, 2024 $ 22 1,673,792 (947,915) (2,994) 6,704 729,609
Ending balance (in shares) at Mar. 31, 2024 223,263,055          
Beginning balance at Dec. 31, 2024 $ 22 1,730,090 (1,012,542) (4,297) 6,258 $ 719,531
Beginning balance (in shares) at Dec. 31, 2024 223,456,994         223,456,994
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   $ 222       $ 222
Issuance of common stock (in shares) 506,632          
Repurchase of common stock (in shares) (227,495) (391,000)       (391,000)
Shares withheld related to net share settlement   $ (498)       $ (498)
Stock-based compensation   1,777       1,777
Stock-based sales incentive charges   17,338       17,338
Net loss     (134,967)   (64) (135,031)
Other comprehensive income (loss)       (52) 0 (52)
Issuance of common stock warrants   2       2
Ending balance at Mar. 31, 2025 $ 22 $ 1,748,540 $ (1,147,509) $ (4,349) $ 6,194 $ 602,898
Ending balance (in shares) at Mar. 31, 2025 223,736,131         223,736,131